US: Bristol-Myers completes Mead Johnson IPO
Bristol-Myers Squibb has launched its infant nutrition unit, Mead Johnson Nutrition Co., onto the New York Stock Exchange, raising US$720m.
In a statement, Bristol-Myers said cash from the Mead Johnson initial public offering will be used to strengthen its capital structure and invest in its biopharma business.
The company sold 30m shares at US$24 per share yesterday (10 February).
Bristol-Myers has retained an 85% stake in Mead Johnson.
Sectors: Baby food
- 2017: three major drivers of M&A strategy
- just-food 2017 Survey - your thoughts on growth
- Food market in 2017: need-to-know US trends
- 2017 - what will shape the UK food sector?
- Could BRF's Turkey move pave way for OneFoods IPO?
- Premier Foods issues profit warning
- UK's Bakkavor plays down IPO "speculation"
- Ferrero insists Nutella not pulled from shelves
- Lindt sees FY sales acceleration on Europe growth
- Unilever sets packaging target